Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Damon Runyon identifies scientists with the highest potential to revolutionize how we prevent, diagnose, and treat all forms of cancer.
Introducing errors in short-lived RNA causes tumors to present antigens on their cell surface, stimulating an immune response.
A new drug to treat acute myeloid leukemia enters clinical trials open to patients as young as one month old.
An interview with former Damon Runyon Clinical Investigator Li Li, MD, PhD, MPH about the role of prevention in the continuum of cancer care
The five scientists with exceptional promise and novel approaches to fighting cancer have been named the 2021 recipients.
Researchers build a functional taxonomy of the tumor suppression genes involved in lung cancer.
A probability approach uncovers gene expression changes in acute lymphoblastic leukemia, the most common form of cancer in children.
By analyzing the genome of the cells in each stage, researchers were able to identify what changes drive the progression of leukemia.
A new technique called CopyKAT can identify genetic abnormalities linked to cancer in a single cell.
Researchers have identified another molecule that may lead to the development of more effective targeted medications.
Experimental monoclonal antibody sotigalimab shows promising results in a Phase I study.
The Damon Runyon Cancer Research Foundation awards $2.8 million to innovative early career scientists.
Damon Runyon Cancer Research Foundation shares some exciting discoveries made by Damon Runyon researchers in 2020.
Damon Runyon researchers are making an impact through understanding the biology and developing novel treatments.
Some patients develop a secondary blood cancer after receiving radiation or chemotherapy treatment for their initial cancer diagnosis
Scientists studied the drug, BO-112, using lab dish experiments and a mouse model of melanoma.
Scientists studied how a series of stepwise mutations in normal blood cells could trigger the transformation to cancer.
After being diagnosed with acute lymphoblastic leukemia, 7 year-old Ryan was officially declared in remission in April 2019.
Results revealed vast cellular diversity in both lung tumors and the tissue surrounding the tumor.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.